Mendelian randomization study of whole blood viscosity and cardiovascular diseases
- PMID: 38669241
- PMCID: PMC11051600
- DOI: 10.1371/journal.pone.0294095
Mendelian randomization study of whole blood viscosity and cardiovascular diseases
Abstract
Aims: Association between whole blood viscosity (WBV) and an increased risk of cardiovascular disease (CVD) has been reported. However, the causal relationship between WBV and CVD remains not thoroughly investigated. The aim of this study was to investigate the causal relation between WBV and CVD.
Methods: Two-sample Mendelian randomization (MR) was employed, with inverse variance weighting (IVW) as the primary method, to investigate the casual relationship between WBV and CVD. The calculated WBV and medical records of 378,210 individuals participating in the UK Biobank study were divided into halves and analyzed.
Results: The means of calculated WBVs were 16.9 (standard deviation: 0.8) and 55.1 (standard deviation: 17.2) for high shear rate (HSR) and low shear rate (LSR), respectively. 37,859 (10.0%) major cardiovascular events (MACE) consisted of 23,894 (6.3%) cases of myocardial infarction (MI), 9,245 (2.4%) cases of ischemic stroke, 10,377 (2.7%) cases of revascularization, and 5,703 (1.5%) cases of coronary heart disease-related death. In the MR analysis, no evidence was found indicating a causal effect of WBV on MACE (IVW p-value for HSR = 0.81, IVW p-value for LSR = 0.47), MI (0.92, 0.83), ischemic stroke (0.52, 0.74), revascularization (0.71, 0.54), and coronary heart disease-related death (0.83, 0.70). The lack of sufficient evidence for causality persisted in other MR methods, including weighted median and MR-egger.
Conclusions: The Mendelian randomization analysis conducted in this study does not support a causal relationship between calculated WBV and CVD.
Copyright: © 2024 Bhak, Tenesa. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
The Impact of Glycated Hemoglobin (HbA1c) on Cardiovascular Disease Risk: A Mendelian Randomization Study Using UK Biobank.Diabetes Care. 2018 Sep;41(9):1991-1997. doi: 10.2337/dc18-0289. Epub 2018 Jun 27. Diabetes Care. 2018. PMID: 29950300
-
The impact of growth differentiation factor 15 on the risk of cardiovascular diseases: two-sample Mendelian randomization study.BMC Cardiovasc Disord. 2020 Oct 28;20(1):462. doi: 10.1186/s12872-020-01744-2. BMC Cardiovasc Disord. 2020. PMID: 33115406 Free PMC article.
-
Causal Association Between Anemia and Cardiovascular Disease: A 2-Sample Bidirectional Mendelian Randomization Study.J Am Heart Assoc. 2023 Jun 20;12(12):e029689. doi: 10.1161/JAHA.123.029689. Epub 2023 Jun 10. J Am Heart Assoc. 2023. PMID: 37301769 Free PMC article.
-
Bidirectional two-sample Mendelian randomization analysis identifies causal associations between cardiovascular diseases and frozen shoulder.J Orthop Surg Res. 2024 Feb 3;19(1):116. doi: 10.1186/s13018-024-04600-7. J Orthop Surg Res. 2024. PMID: 38310246 Free PMC article.
-
The role of mitochondrial DNA copy number in cardiometabolic disease: a bidirectional two-sample mendelian randomization study.Cardiovasc Diabetol. 2024 Jan 28;23(1):45. doi: 10.1186/s12933-023-02074-1. Cardiovasc Diabetol. 2024. PMID: 38282013 Free PMC article. Review.
References
-
- Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al.. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The lancet. 2012;380(9859):2095–128. doi: 10.1016/S0140-6736(12)61728-0 - DOI - PMC - PubMed
-
- Gori T, Wild PS, Schnabel R, Schulz A, Pfeiffer N, Blettner M, et al.. The distribution of whole blood viscosity, its determinants and relationship with arterial blood pressure in the community: cross-sectional analysis from the Gutenberg Health Study. Therapeutic Advances in Cardiovascular Disease. 2015;9(6):354–65. doi: 10.1177/1753944715589887 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources